Latest Articles

Publication Date
Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer - Targeted Oncology

Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer Targeted Oncology

Published: Feb. 6, 2026, 10:05 p.m.
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? - Oncology Nursing News

How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? Oncology Nursing News

Published: Feb. 5, 2026, 5:03 p.m.
TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight - The Malaysian Reserve

TIGIT Inhibitors Market Poised for Strong Growth Through 2034, Driven by Expanding Immuno-Oncology Pipeline | DelveInsight The Malaysian Reserve

Published: Feb. 2, 2026, 11:43 p.m.
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - Targeted Oncology

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment Targeted Oncology

Published: Jan. 28, 2026, 10:02 p.m.
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - The Manila Times

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress The Manila Times

Published: Jan. 23, 2026, 1:20 p.m.
Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress - manilatimes.net

Acrivon Therapeutics Announces Late-Breaking Oral Presentation at Upcoming European Society of Gynecological Oncology (ESGO) Annual International Congress manilatimes.net

Published: Jan. 23, 2026, 1:20 p.m.
Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer - Targeted Oncology

Fruquintinib/Sintilimab Yields Efficacy, Safety in Advanced pMMR Endometrial Cancer Targeted Oncology

Published: Jan. 22, 2026, 4:02 p.m.
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? - Oncology Nursing News

Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? Oncology Nursing News

Published: Jan. 14, 2026, 7:32 p.m.
No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

No checkpoint glory for Acrivon | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Published: Jan. 12, 2026, 1:11 p.m.
Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer - Targeted Oncology

Novel Small Molecule Inhibitors Show Efficacy in Endometrial Cancer Targeted Oncology

Published: Jan. 11, 2026, 4:14 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!